Dr. Chih-Yi Liao
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Area of expertise
Pancreatic Cancer
Chih-Yi Liao has run 5 trials for Pancreatic Cancer. Some of their research focus areas include:
Pancreatic Neuroendocrine Tumors
Chih-Yi Liao has run 4 trials for Pancreatic Neuroendocrine Tumors. Some of their research focus areas include:
Affiliated Hospitals
University Of Chicago Comprehensive Cancer Center
UC Comprehensive Cancer Center At Silver Cross
Clinical Trials Chih-Yi Liao is currently running
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting
1 award
Phase 2
3 criteria
Targeted Alpha-Particle Therapy
for Neuroendocrine Tumors
This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Recruiting
1 award
Phase 1 & 2
13 criteria
More about Chih-Yi Liao
Clinical Trial Related
3 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Chih-Yi Liao has experience with
- Temozolomide
- Capecitabine
- Trastuzumab
- Tucatinib
- Fluorouracil
- Lutetium Lu 177 Dotatate
Breakdown of trials Chih-Yi Liao has run
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Cancer
Bile Duct Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chih-Yi Liao specialize in?
Chih-Yi Liao focuses on Pancreatic Cancer and Pancreatic Neuroendocrine Tumors. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Chih-Yi Liao currently recruiting for clinical trials?
Yes, Chih-Yi Liao is currently recruiting for 6 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Chih-Yi Liao has studied deeply?
Yes, Chih-Yi Liao has studied treatments such as Temozolomide, Capecitabine, Trastuzumab.
What is the best way to schedule an appointment with Chih-Yi Liao?
Apply for one of the trials that Chih-Yi Liao is conducting.
What is the office address of Chih-Yi Liao?
The office of Chih-Yi Liao is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.